Provides Individual & Family health insurance plans. Offers Small Group health insurance plans for businesses. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
Average growth of 57% a year over the last 4 years. Red columns mark years that ended in a loss.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
This company is not turning a profit, so the market is pricing its sales instead: 0.7× for every dollar of annual revenue.
Against companies in its own sector, it looks cheaper than 95% of them.
Analysts' average target sits 17% below today's price.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Over the last 4 years, sales grew about 57% a year on average.
The company sells $11.7B a year; the problem isn’t sales — it’s costs running above that number.
There is $4.0B in the vault; even if every debt were paid off, $3.6B would remain.
A loss of $443.2M against $11.7B in annual sales.
This stock swings about 2.4 times as much as the market average. Big rallies — and big drops — can both happen fast.
The stock trades 17% above the average analyst price target.
On our five-subject report card, OSCR sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: OSCR has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.
Not covered, because the filings we hold do not carry it: the revenue breakdown.